BURLINGTON, Mass. and FRISCO, Texas, USA – Keurig Dr Pepper (KDP) yesterday announced that Oray Boston, Worldwide President of Trauma, Extremities, Craniomaxillofacial and Animal Health for DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, has been elected as a Director of the KDP Board, effective Nov. 14, 2022.
During his 30-year tenure at Johnson & Johnson that has included leadership positions in operations, sales and marketing, Boston led cross-functional and cross-sector teams that delivered commercial growth and differentiated innovation.
Prior roles held by Boston included President of Global Biosurgery, Vice President of Sales & Marketing and Worldwide Vice President of Franchise Operations at Ethicon, a Johnson & Johnson MedTech company.
Boston has served as National Co-Chair of Johnson & Johnson’s African Ancestry Leadership Council and is currently a member of the CEO Council for Growth of Philadelphia.
Commenting on the announcement, KDP Chairman and CEO Bob Gamgort stated, “Oray is a highly experienced and seasoned executive who will bring additional depth and perspective to our Board. We are pleased to welcome him as our newest Director.”
About Keurig Dr Pepper (KDP)
Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue approaching $13 billion and approximately 27,000 employees.
KDP holds leadership positions in soft drinks, specialty coffee and tea, water, juice and juice drinks and mixers, and markets the #1 single serve coffee brewing system in the U.S. and Canada.
